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Perceptions and experiences of taking oral hypoglycaemic
agents among people of Pakistani and Indian origin:
qualitative study
Julia Lawton, Naureen Ahmad, Nina Hallowell, Lisa Hanna, Margaret Douglas
Abstract
Objective To explore British Pakistani and British
Indian patients’ perceptions and experiences of taking
oral hypoglycaemic agents (OHAs).
Design Observational cross sectional study using
in-depth interviews in English or Punjabi.
Setting and participants 32 patients of Pakistani and
Indian origin with type 2 diabetes, recruited from
primary care and community sources in Edinburgh,
Scotland.
Results Respondents reported complex and
ambivalent views about OHAs, which reflected their
ambivalent attitudes towards Western drugs in
general. Respondents considered OHAs to be an
important part of the diabetic regimen because they
perceived British healthcare professionals to be
competent and trustworthy prescribers, and they
considered the medicines available in Britain to be
superior to those on the Indian subcontinent. Despite
this, some respondents made deliberate efforts to
reduce their tablet intake without being advised to do
so. Reasons for this included perceptions that drugs
worked by providing relief of symptoms and concerns
that OHAs could be detrimental to health if taken for
long periods, in conjunction with other drugs, or
without traditional foods.
Conclusions British Pakistani and Indian patients’
perceptions of their OHAs may partly derive from
popular ideas about drugs on the Indian
subcontinent. Cultural factors need to be understood
and taken into consideration to ensure that these
patients are given appropriate advice and to avoid
unnecessary changes to prescriptions.
Introduction
People of South Asian origin resident in Britain with
type 2 diabetes have a higher risk of complications and
a 40% higher mortality, partly because their blood glu-
cose control is poorer than that of white patients.1 2
South Asian patients may be less anxious than white
patients about adhering to treatments and may attach
less importance to controlling their diabetes.3
In this study, we used a patient centred approach to
a hitherto unstudied area—the attitudes of Pakistani
and Indian patients with type 2 diabetes towards, and
experiences of, taking oral hypoglycaemic agents
(OHAs). Our objective was to inform their future care,
as minority ethnic patients respond well to health
related advice if it is delivered in ways that are sensitive
to their views and cultural backgrounds.4
Methods
We used single, in-depth interviews that encouraged
respondents to display their own understandings and
meanings and permitted themes and hypotheses to be
identified and tested during the study that might not
have been initially anticipated. A bilingual research fel-
low (NA) fluent in English and Punjabi did all the
interviews.
Recruitment and sample—We recruited patients from
five general practices in Edinburgh, with a high
proportion of Pakistani and Indian patients. Health-
care professionals contacted patients by letter (in Eng-
lish, Urdu, and Punjabi), inviting them to “opt in.” We
also used face to face recruitment and snowballing to
access respondents from Edinburgh’s Pakistani and
Indian communities, trying to include hard to reach
groups. All respondents were either Indian (n = 9) or
Pakistani (n = 23) (the proportions reflect the demog-
raphy of South Asians in Scotland (2001 census)), aged
18 years and over, with type 2 diabetes. We purposively
sampled respondents on the basis of their age, sex,
length of time since diagnosis, and preferred language
(see bmj.com). Recruitment continued until no new
themes emerged from the interviews.
Data collection—Interviews were conducted in Eng-
lish and Punjabi. Respondents were informed that NA
was not a healthcare professional and were reassured
about confidentiality. Interviews normally took place in
respondents’ homes, averaged one hour, and were tape
recorded. Interviews were translated into English and
transcribed in full.We contacted some respondents after
interview to clarify issues and validate findings.
Analysis—The study was informed by grounded
theory, which involves concurrent data collection and
analysis, together with systematic efforts to check and
refine developing categories of data. Themes and
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hypotheses identified in early interviews informed later
interviews. Team members independently reviewed
interview data, and regular meetings were held to
explore respondents’ underlying reasoning, discuss
deviant cases, and agree on findings.
Results
Twenty nine of the 32 respondents took OHAs, and
three were controlled by diet. Responses did not differ
according to type of treatment, method of recruitment,
or characteristics of respondents.
Initial reactions to taking OHAs
Respondents expressed some initial trepidation about
taking OHAs, as they perceived this as signifying that
their condition had deteriorated and they had taken on
the identity of a sick person: “I was devastated [about
being prescribed glipizide]. I wasn’t happy at all. But it
was explained to me that diabetes always progresses,
no matter how careful you are.” (R1, Pakistani, female)
Perceptions of OHAs
Despite their initial concerns, most respondents
perceived OHAs as an essential part of their diabetic
regimen: “Once you start on these then you have to be
on them for the rest of your life. So either you do that,
or you risk dying. So you have no choice but to take the
medicine.” (R12, Pakistani, female)
The importance attached to OHAs stemmed partly
from respondents’ perception that these drugs were
more effective and of a better quality than those from
the Indian subcontinent: “See, in Pakistan, the medica-
tions are not right, they’re just a waste of time, waste of
money. I mean these [referring to OHAs] are the real
stuff. These are what really work.” (R7, Pakistani, male)
Additionally, respondents considered British
healthcare professionals to be competent and trust-
worthy. Most had had experiences of professionals and
services on the Indian subcontinent and used these as
a benchmark to assess the quality of care received in
Britain. Many respondents described health profes-
sionals on the Indian subcontinent as untrustworthy:
“You know how it is there, our doctors don’t really pay
attention. They are more concerned with the amount
of money they are making. First they will give you a
lighter medication, which will make you go back to
them again and again until they give you something
else.” (R13, Pakistani, female)
In contrast, British health professionals were seen
as “dealing with everybody the same . . . they will treat
according to their condition” (R16, Pakistani, female),
because they were paid directly by the NHS and did
not gain financially from dispensing prescriptions.
Most respondents claimed they had not sought out
other treatments for their diabetes, such as herbal rem-
edies, either in Britain or during visits to the Indian
subcontinent.
Self regulation of OHAs
Less than half the respondents prescribed OHAs
reported taking them as prescribed. Fifteen people
described how they routinely adjusted the amount of
tablets they took. Most attempted to reduce their tablet
intake.
Many respondents saw it as unnecessary to take all
of their OHAs when they felt well: “Sometimes you do
say that to yourself, you know, you say to yourself, ‘Oh
I feel fine and I’ll take one today, I won’t take two.’ ”
(R27, Pakistani, female)
Some respondents also described deliberately skip-
ping tablets to mitigate unpleasant short term side
effects, without consulting or reporting these to health
professionals: “So when I took them I would feel so
much heat and I would suddenly become dizzy. So then
I didn’t take them.” (R23, Pakistani, female)
Other respondents reduced their OHA intake when
fasting or having to skip a meal, usually without seeking
medical advice. These respondents were reluctant to
take their OHAs without eating traditional foodstuffs, as
these foods were perceived as having fortifying
properties that balanced out, or counteracted, the side
effects of their OHAs: “If you keep on taking tablets and
not eating strengthening foods like roti, then they will
affect you. If you eat strengthening foods . . . they will not
produce dryness.” (R16, Pakistani, female)
A few Pakistani respondents said that health
professionals had advised them to alter their OHA
intake during Ramadan and, because of this, thought
they could reduce their tablets on other occasions, even
though they had not been advised to do so.
Respondents articulated concerns that, if taken in
excess or over long periods, OHAs could be detrimen-
tal to their health: “Yes, they told me to take it everyday,
but I said ‘do I want to die by taking it everyday. . . I
don’t want to die by taking so many.’ ” (R4, Pakistani,
female)
Some respondents attributed the onset of their dia-
betes to drugs they had been prescribed for other con-
ditions, such as asthma, anaemia, and pneumonia and
expressed anxieties about taking OHAs with other
drugs.
In a few cases, respondents also believed that taking
several medications together could counteract their
individual effects: “Instead of giving too many tablets
why don’t they give one instead? Like you drink tea and
it’s good for your health, but if you drink tea too hot or
you add something to it then there is no point in
drinking the tea. It’s only worth it if you could have two
tablets instead of say 50.” (R25, Pakistani, male)
Self regulation strategies
Self monitoring
Most commonly, respondents self monitored their
blood glucose and took all their tablets only when they
considered their readings to be high: “And now in the
morning I take three pills, sometimes two, meaning I
check it [blood glucose] and according to that I do or
don’t take all the pills.” (R5, Pakistani, male)
In some cases, respondents were unaware of
appropriate levels for blood glucose control. One man,
for example, claimed that he only took all of his
prescribed tablets when “it goes out of control at 18 or
19.” (R26, Pakistani male)
Reducing food intake
A few respondents described how they deliberately
reduced the amount of food they consumed, or skipped
meals, so that they could take fewer tablets: “Sometimes
I will take two when I don’t spread too much jam on my
toast or even sometimes I don’t even spread any. If I feel
like a bit of a pleasure then I will put some on and then
I will take the extra tablets.” (R19, Pakistani, male)
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Discussion
We identified various factors that may influence
Pakistani and Indian patients’ adherence to oral
hypoglycaemic agents. These included confidence in
British healthcare professionals as prescribers, percep-
tions of Western medicines as efficacious, expectations
that drugs should provide instant relief of symptoms,
and beliefs that Western medicines can have detrimen-
tal effects if taken in excess or without traditional food-
stuffs. Respondents had to balance these competing
concerns, which could lead them to self regulate their
OHAs in ways that they saw as rational but that went
against medical advice.
Popular ideas about medicines, derived from the
Indian subcontinent, may have informed the ways
respondents took their OHAs. On the Indian subconti-
nent, people commonly self medicate, make selective
use of prescribed drugs, and abandon drugs that do
not provide prompt relief of symptoms.5 6 Respond-
ents’ concerns about taking OHAs in excess may
derive from popular ideas that Western drugs are pow-
erful but inherently dangerous.7
Health professionals should try to establish how
Pakistani and Indian patients actually take their OHAs,
as elevated glucose or glycated haemoglobin levels
might be due to missed doses rather than underpre-
scribing. Dietary beliefs and practices should be
explored as part of the consultation. Health profes-
sionals should question Pakistani and Indian patients
directly and opportunistically about side effects and
health problems they may be having, and stress the
importance of presenting if problems arise. Key to
improving adherence is good health provider-patient
communication (box).8 Bilingual link workers may
have an important part to play here.
Strengths and limitations
This is the first qualitative study to look in depth at
British Pakistani and Indian patients’ perceptions and
experiences of taking OHAs. We did not use
translators during the interviews, thereby enhancing
the quality of the data. As we did not have access to
respondents’ clinical records, and did not use a
longitudinal design, we cannot determine the effect of
adjustment of OHAs on glycaemic control. A further
limitation arises from the absence of qualitative work
involving members of the general population or other
minority ethnic groups that can be used for compara-
tive purposes. This should be a priority for future
research. Finally, as this study focused on Indian and
Pakistani patients, most of whom emigrated from the
Punjab region, this may limit the generalisability of the
findings to other South Asians.
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patients who took part, and the members of our advisory group.
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Key recommendations for health professionals
In order to identify and counter beliefs that may
influence adherence to oral hypoglycaemic agents
(OHAs), health professionals should:
• Be aware that some Pakistani and Indian patients
may adjust OHA treatment according to symptoms
• Ask patients in a non-judgmental way if they adjust
their drugs themselves
• Explore individual patients’ understandings of and
concerns about taking OHAs
• Be aware that some Pakistani and Indian patients
perceive the need to balance “strong” OHA drugs with
dietary changes (that may not be appropriate to their
diabetes management)
• Ask patients if (and how) they adjust their diet
because of their OHA treatment and vice versa
• Ask patients directly about any symptoms they
attribute to their diabetes and their treatment
What is already known on this topic
Poor adherence to prescribed oral hypoglycaemic
agents (OHAs) presents a serious problem for
professionals who deliver diabetes care
British South Asian patients have poor blood
glucose control compared with white patients and
may be less adherent to their treatment regimens
Adherence can be improved when patients are
approached in culturally sensitive ways
What this study adds
British Pakistani and Indian patients have
ambivalent attitudes towards OHAs, which may
partly derive from popular ideas about Western
drugs on the Indian subcontinent
Pakistani and Indian patients’ beliefs about
Western medicines may lead them to self regulate
their OHAs in ways that seem rational to them but
go against medical advice
Health professionals need to establish how and
why patients take their OHAs in order to improve
adherence and glycaemic control
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